Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
2
×
new york blog main
new york top stories
san diego blog main
san diego top stories
2
×
san francisco
2
×
san francisco blog main
san francisco top stories
startups
2
×
accelerator
acetylon pharmaceuticals
airbnb
amazon web services (aws)
ambys medicines
artificial intelligence (a.i.)
athelas
atomwise
benchling
biotech
biotechnology
cancer
cell therapy
coinbase
constellation pharmaceuticals
coworking
cruise
culture biosciences
data analytics
detroit blog main
detroit top stories
doordash
dropbox
drug development
drugs
entrepreneurship
What
big
2
×
startup
admits
ago
aiming
ambys
biotech
biotechs
classes
combinator
companies
control
deadly
deal
debuted
diseases
dug
formed
future
incubator
launch
life
liver
make
medicines
new
previously
sciences
sizable
started
takeda
tech
they’re
today
treatments
unusual
variety
welcome
years
Language
unset
Current search:
big
×
startups
×
" san francisco "
×
" national top stories "
×
" san diego top stories "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?